An Exploration of Key Issues in IBD: A CME/CE-Certified Microlearning Series

Download All
Learn the latest recommendations for switch therapy when patients with UC or CD fail TNF inhibitor therapy
Bruce E. Sands, MD, MS

Next Steps Following TNF Inhibitor Failure in IBD

In this concise video, review recommendations for therapeutic drug monitoring of TNF-α inhibitor therapy and hear expert discussion of key data informing second-line treatment decisions of moderate to severe UC and CD following TNF-α inhibitor failure.

Bruce E. Sands, MD, MS Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: May 24, 2021 Expired: May 23, 2022

Learn about current guideline recommendations for therapeutic drug monitoring of TNF-α inhibitor therapy and review key data informing second-line treatment decisions of moderate to severe UC and CD following TNF-α inhibitor failure.

Bruce E. Sands, MD, MS Released: May 24, 2021

My take on TDM for patients receiving TNF-α inhibitors for IBD.

Bruce E. Sands, MD, MS Released: June 3, 2021
Provided by Clinical Care Options

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
AbbVie
Bristol-Myers Squibb

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue